KindlyMD, Inc.

NAKA Financial Capital Markets

KindlyMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 million, down 33.0% from fiscal 2024. In the quarter to June 2026, revenue grew 8,680.7%, EPS grew 52.5% and free cash flow fell 25.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

7.13 0.96 −11.87%
Market cap
$144.8M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
109.72 31.51 32.50 1.99
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(16.50) (9.29) (6.04) (24.29)
P/B ratio
0.46 0.14 0.38 0.33
EV/Sales
97.51 22.07 24.35 1.51
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(0.28) (0.07) (0.14) (0.09)
Current Ratio
0.13 1.04 0.25 0.15
Net Debt/EBITDA
2.32 0.11 0.28 0.46
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(103.74%) (247.86%) (488.69%) (907.59%)
Free Cash Flow Yield
(322.69%) (1,028.19%) (532.29%) (870.81%)
Free Cash Flow per Share
(128.94) (4.26) (0.41) (0.27)
Book value per Share
94.06 102.75 23.07 11.82
Free Cash Flow
(654.65) (21.34) (6.59) (5.35)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates